19th October 2026. NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT Australian biotechnology company Skin Elements Limited (ASX:SKN) (SKN, the Company) has completed an allotment in the Company of 18,000,000 fully paid ordinary shares in the capital of the Company (Shares). An appendix...
Notice under section 708A(5)(e) of the corporations act
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The company completed the allotment of fully paid ordinary shares without disclosure under the relevant part of the Corporations Act. It confirms compliance with various provisions of the Corporations Act and states there is no excluded information that needs disclosure.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Skin Elements
- Application for quotation of securities - SKN
- Notification of cessation of securities - SKN
- Appendix 4G and Corporate Governance Statement
- Annual Report to shareholders
- Appendix 4E & Preliminary Final Report
Later from Skin Elements
- Trading Halt
- Skin Elements secures $700k Placement
- Proposed issue of securities - SKN
- Executive Leadership Transition
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Skin Elements into a list and get an email when it puts out news.
Follow Skin Elements